About SH Pharmaceuticals Limited
Data last updated:
SH Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1995PLC021887. Its GSTIN is 36AACCS8276P1ZI (Telangana). The company holds 16 GST registrations, of which 10 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.27 Cr. It is led by directors including Sanjay Chillakuru Reddy and Aditya Tikkavarapu Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.2 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹1.37 Cr (net margin -9%) and EBITDA of -₹1.55 Cr (EBITDA margin -10.2%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.
The company has about 164 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.5 Cr and satisfied charges of ₹25 Lakh on record. Court records list 20 cases involving the company, including 14 filed by the company and 6 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address6 – 3 – 348 Midtown6Thfloor Bblock Roadno.1 Banjar, A Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of SH Pharmaceuticals Limited
The main business activity of SH Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of SH Pharmaceuticals Limited FY 2025 filings available
SH Pharmaceuticals Limited reported revenue of ₹15.2 Cr (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of SH Pharmaceuticals Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 20% fall in the latest year. EBITDA fell 323% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of SH Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.37 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of SH Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SH Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of SH Pharmaceuticals Limited
SH Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gangesh Pharma Private Limited | ₹15.27 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Tribeni Resources Pvt Ltd | ₹15.24 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Kolkata, West Bengal, India |
| Disruptive Health Solutions Private Limited | ₹15.23 Cr (FY 2022) | •••• | •••• | 21.0% | •••• | New Delhi, Delhi, India |
| Bagaria Chemicals Private Limited | ₹15.22 Cr (FY 2025) | •••• | •••• | -40.0% | •••• | New Delhi, Delhi, India |
| Citizenplus Pharmaceuticals Private Limited | ₹15.21 Cr (FY 2022) | •••• | •••• | 116.0% | •••• | Hyderabad, Telangana, India |
| SH Pharmaceuticals Limited this company | ₹15.2 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Hyderabad, Telangana, India |
| Dermatica Laboratories Private Limited | ₹15.2 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Thane, Maharashtra, India |
| Eumark Pharmaceuticals Pvt Ltd | ₹15.13 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Ambernath, Maharashtra, India |
| J J Parikh Pharma Pvt Ltd | ₹15.1 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Medisearch Laboratories (Bombay) Private Limited | ₹15.07 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Thane, Maharashtra, India |
| Juve Trexim Private Limited | ₹15.06 Cr (FY 2025) | •••• | •••• | 680.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below SH Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of SH Pharmaceuticals Limited
SH Pharmaceuticals Limited is audited by MURTHY & KANTH for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MURTHY & KANTH | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of SH Pharmaceuticals Limited
SH Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Chillakuru Reddy Also directs: Deepaditya Developers India LLP, Jivanta Life Sciences LLP, Epsi Building Management Services LLP and 5 more | Director | 10 May 2005 | 21 Years 5 Months | Current |
| Bala Lanka Bhaskar Also directs: Integrum Realtors LLP, Aniksan Infra Private Limited | Additional Director | 28 Aug 2008 | 18 Years 1 Months | Current |
| Aditya Tikkavarapu Reddy Also directs: Deepaditya Developers India LLP, Epsi Building Management Services LLP, Mondo Foods LLP and 5 more | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
| Sudhakar Malisetti | Director | 10 May 2005 | 21 Years 5 Months | Current |
Ownership and Shareholding of SH Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of SH Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2013 | Hdfc Bank Limited | ₹2.5 Cr | Open |
| 06 Mar 2009 | State Bank of India | ₹25 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of SH Pharmaceuticals Limited
SH Pharmaceuticals Limited has 20 court cases on record: 14 filed by SH Pharmaceuticals, 6 filed against it. 1 case is pending and 19 are disposed. Status as checked between 28 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 4 | 1 |
| High courts | 8 | 2 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by Safexpress Private Limited | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by Safexpress Private Limited | Disposed |
| High Court for State of Telangana | Appeal | Filed by the company against Aptonline Limited | Disposed |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed by the company against Poonam Pharmaceuticals | Disposed |
| Calcutta High Court | Court case (FMA) | Filed by the company against an individual | Disposed |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at SH Pharmaceuticals Limited
SH Pharmaceuticals Limited has a workforce of 164 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of SH Pharmaceuticals Limited
SH Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230AP1995PLC021887. The current CIN is U24230TG1995PLC021887, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1995PLC021887 | Current |
| U24230AP1995PLC021887 | Previous |
Recent Activity on SH Pharmaceuticals Limited
SH Pharmaceuticals Limited has 5 board changes on record since 2005: 4 appointments and 1 cessation. The latest: Aditya Tikkavarapu Reddy ceased to be Additional Director on 31 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for SH Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by SH Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of SH Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of SH Pharmaceuticals Limited
SH Pharmaceuticals has 16 GST registrations: 10 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS8276P1ZI | Telangana | Active | 01 Jul 2017 |
| 09AACCS8276P1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AACCS8276P1ZW | Bihar | Active | 01 Jul 2017 |
| 18AACCS8276P1ZG | Assam | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of SH Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SH Pharmaceuticals Limited
SH Pharmaceuticals is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 1995 (31+ years old) and is registered under CIN U24230TG1995PLC021887.
SH Pharmaceuticals reported revenue of ₹15.2 Cr for FY 2025 (down 20% YoY).
SH Pharmaceuticals has 4 current directors:
- Sanjay Chillakuru Reddy - Director
- Bala Lanka Bhaskar - Additional Director
- Aditya Tikkavarapu Reddy - Director
- Sudhakar Malisetti - Director
SH Pharmaceuticals reported a net loss of ₹1.37 Cr (net margin -9%) and EBITDA of -₹1.55 Cr (EBITDA margin -10.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of SH Pharmaceuticals is -6% over three years and -1% over five years. In the latest year (FY 2025) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of SH Pharmaceuticals is 36AACCS8276P1ZI, registered in Telangana. The company has 16 GST registrations in all, of which 10 are active and 6 are cancelled or inactive. Other active GSTINs include 09AACCS8276P1ZF (Uttar Pradesh), 10AACCS8276P1ZW (Bihar), 18AACCS8276P1ZG (Assam).
The CIN (Corporate Identification Number) of SH Pharmaceuticals is U24230TG1995PLC021887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SH Pharmaceuticals has 20 court cases on record: 14 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
SH Pharmaceuticals was incorporated on 29 September 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of SH Pharmaceuticals by revenue are Gangesh Pharma Private Limited, Tribeni Resources Pvt Ltd, Disruptive Health Solutions Private Limited, Bagaria Chemicals Private Limited, Citizenplus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Aditya Tikkavarapu Reddy ceased to be Additional Director on 31 Dec 2020. Aditya Tikkavarapu Reddy was appointed as Director on 16 Oct 2020. Bala Lanka Bhaskar was appointed as Additional Director on 28 Aug 2008. SH Pharmaceuticals has 5 board changes on record in total.